The authors highlight the 2025 ACG Guideline on malnutrition and nutritional recommendations in liver disease, emphasizing early screening, individualized nutritional goals, and targeted supplementation to improve outcomes across various etiologies and stages of chronic liver disease.
Can We Avoid Colonoscopies in Lynch Syndrome?
Can non-invasive fecal immunochemical tests be used to extend surveillance intervals for colonoscopy among Lynch syndrome patients?
Sphincterotomy to prevent PEP after FCSEMS placement
EBGI summary reviews the 2025 SPHINX study published in Gut on endoscopic sphincterotomy to prevent post-ERCP pancreatitis after self-expandable metal stent placement for distal malignant biliary obstruction.
IBD Surveillance Colonoscopy: to Spray or Not to Spray!
EBGI summary discussed a RCT from the Netherlands that examines neoplasia detection rates in individuals with IBD without active inflammation who were scheduled for endoscopic surveillance randomized to HD white-light endoscopy with segmental reinspection, single-pass HD white-light endoscopy, or to HD chromoendoscopy.
Optimizing Bowel Preparation for Colonoscopy: Insights from the USMSTF Recommendations
High-quality colonoscopy is essential for evaluation of the colon, such as de-tecting and monitoring precancerous le-sions. Suboptimal bowel preparation decreases colonoscopy efficacy and is as-sociated with significant adenoma and advanced adenoma miss rates. This summary reviews the USMSTF recommendations on optimizing bowel preparation for colonoscopy.
Increased ATTENTION to Early Initiation of Antiviral Therapies in Chronic Hepatitis B Based on Viral Load
This evidence-based summary examines a RCT which aimed to assess the efficacy of early antiviral treatment with tenofovir alafenamide in patients with non-cirrhotic chronic HBV and moderate to high viremia.
Challenges of Full FDA Approval for Obeticholic Acid Based on Reduction of Hepatic PBC Clinical Events
This summary reviews the challenges of FDA approval for obeticholic acid in an evidence-based review of the COBALT study.
Tulisokibart: A New Drug for Moderate-to-Severe UC That May Come With Personalized Medicine
Tulisokibart: A New Drug for Moderate-to-Severe UC That May Come With Personalized Medicine Ellen Axenfeld, MD1 and Elie S. Al…
Underwater EMR for Medium Sized Colorectal Sessile Polyps
Underwater EMR for Medium Sized Colorectal Sessile Polyps Mohammad Bilal, MD, FACG Associate Professor of Medicine, University of Colorado Anschutz…
Optimal Colorectal Cancer Prevention With Stool Tests Depends on High Quality Colonoscopy
Optimal Colorectal Cancer Prevention With Stool Tests Depends on High Quality Colonoscopy Joseph C. Anderson, MD, FACG VA Medical Center,…